<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0124-7107</journal-id>
<journal-title><![CDATA[Universidad y Salud]]></journal-title>
<abbrev-journal-title><![CDATA[Univ. Salud]]></abbrev-journal-title>
<issn>0124-7107</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Nariño]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0124-71072022000100095</article-id>
<article-id pub-id-type="doi">10.22267/rus.222401.261</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Factores de adherencia al tratamiento de hipertensión arterial en servicios de primer nivel de atención]]></article-title>
<article-title xml:lang="en"><![CDATA[Adherence factors to hypertension treatment in primary care services]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Solís]]></surname>
<given-names><![CDATA[Aicardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bergonzoli-Peláez]]></surname>
<given-names><![CDATA[Gustavo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Contreras-Rengifo]]></surname>
<given-names><![CDATA[Adolfo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Cali  ]]></institution>
<addr-line><![CDATA[Cali ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Fundación para la Producción y Gestión del Conocimiento  ]]></institution>
<addr-line><![CDATA[Cali ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Departamental Tomas Uribe Uribe  ]]></institution>
<addr-line><![CDATA[Tuluá Valle del Cauca]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad del Valle Escuela de Odontología Grupo de Medicina Periodontal]]></institution>
<addr-line><![CDATA[Cali ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2022</year>
</pub-date>
<volume>24</volume>
<numero>1</numero>
<fpage>95</fpage>
<lpage>101</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0124-71072022000100095&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0124-71072022000100095&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0124-71072022000100095&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción:  La enfermedad arterial hipertensiva no controlada (EAHNC), se asoció en 2008 con alta mortalidad por enfermedad cardiovascular que genera 9,4 millones de fallecimientos y 7% de la carga de enfermedad expresada en Años de Vida Ajustados por Discapacidad (AVAD). Un 50% de los pacientes no se adhieren al tratamiento EAH y se desconoce sobre las causas en el nivel básico de atención en Colombia.  Objetivo:  Identificar factores asociados con la adherencia al tratamiento de EAH en una Empresa Social del Estado (E.S.E), pública de un municipio colombiano.  Materiales y métodos:  Estudio de casos y controles, 75 casos y 75 controles seleccionados aleatoriamente a partir de una base de pacientes del programa de control de hipertensión arterial.  Resultados:  La edad mayor a 50 años fue el único factor asociado con falta de adherencia al tratamiento, sujetos entre 50-59 años con un OR=3,18 (Intervalo al 95% de confianza) IC95% 1,01-10,00; y entre 60-69 años OR=3,70 IC95% 1,17-11,60 tienen mayor probabilidad de no adherirse al tratamiento.  Conclusiones:  Los mayores de 50 a 69 años de edad presentaron la más alta probabilidad de no adherencia al tratamiento de la EAH. Se requieren reforzar medidas de seguimiento para mejorar su adherencia al tratamiento.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction:  In 2008, uncontrolled hypertensive arterial disease (UHAD) was associated with a high cardiovascular mortality that caused 9.4 million deaths and 7% of the disease burden expressed as Disability-Adjusted Life Years (DALYs). The reasons why 50% of the patients treated in primary care facilities in Colombia do not adhere to UHAD treatment are unknown.  Objective:  To identify factors associated with UHAD treatment adherence in a Public Health Care institution from a Colombian city.  Materials and methods: A case-control study with 75 cases and 75 controls randomly selected from a patient database of the arterial hypertension control program.  Results:  Being older than 50 years was the only factor associated with lack of adherence to treatment. Participants who were 50-59 (OR=3.18; IC95% 1.01-10.00) and 60-69 (OR=3.70; IC95% 1.17-11.60) are less likely to adhere to treatment.  Conclusions:  Patients who are 50-69 years old had the highest probability of non-adherence to UHAD treatment. Follow-up measures are necessary to improve this figure.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Hipertensión]]></kwd>
<kwd lng="es"><![CDATA[adherencia al tratamiento]]></kwd>
<kwd lng="es"><![CDATA[estudios de casos y controles]]></kwd>
<kwd lng="es"><![CDATA[regresión logística]]></kwd>
<kwd lng="en"><![CDATA[Hypertension]]></kwd>
<kwd lng="en"><![CDATA[treatment adherence and compliance]]></kwd>
<kwd lng="en"><![CDATA[case-control studies]]></kwd>
<kwd lng="en"><![CDATA[logistic models]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Es Hora de Actuar: Informe de La Comisión Independiente de Alto Nivel de La OMS Sobre Enfermedades No Transmisibles]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lim]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Vos]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Flaxman]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
<name>
<surname><![CDATA[Danaei]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Shibuya]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Adair-Rodahi]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010]]></article-title>
<source><![CDATA[The Lancet]]></source>
<year>2012</year>
<volume>380</volume>
<numero>9859</numero>
<issue>9859</issue>
<page-range>2224-60</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Informe Sobre La Situación Mundial de Las Enfermedades No Transmisibles 2014: "Cumplimiento de Las Nueve Metas Mundiales Relativas a Las Enfermedades No Transmisibles: Una Responsabilidad Compartida"]]></source>
<year>2014</year>
<page-range>16</page-range><publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Información General Sobre a Hipertensión en el Mundo: Una Enfermedad Que Mata en Silencio, Una Crisis de Salud Pública Mundial]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="">
<collab>World Health Organization</collab>
<collab>World Economic Forum</collab>
<source><![CDATA[From Burden to "Best Buys ": Reducing the Economic Impact of Non-Communicable Diseases in Low- and Middle-Income Countries]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>Organización Panamericana de la Salud</collab>
<collab>Universidad de Washington</collab>
<source><![CDATA[Las Dimensiones Economicas de Las Enfermedades No Transmisibles En America Latina y El Caribe]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Washington D.C ]]></publisher-loc>
<publisher-name><![CDATA[Organización Mundial de la Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<collab>Organización Panamericana de la Salud</collab>
<source><![CDATA[Salud En Las Américas+, Edición Del 2017. Resumen: Panorama Regional y Perfiles de País]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Washington D.C ]]></publisher-loc>
<publisher-name><![CDATA[Organización Mundial de la Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="">
<collab>Fondo Colombiano de Enfermedades de Alto Costo</collab>
<source><![CDATA[Situación La Enfermedad Renal Crónica, La Hipertensión Arterial y La Diabetes Mellitus En Colombia - 2018]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Colombia ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="">
<collab>ESE Hospital Santa Margarita</collab>
<source><![CDATA[Perfil Epidemiológico de La E.S.E Hospital Santa Margarita. Información Del Departamento de Estadística Relacionado Hipertensión Arterial y Factores Asociados]]></source>
<year>2012</year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="">
<collab>IBM Corporation</collab>
<source><![CDATA[IBM SPSS Statistics for Windows, Version 24.0]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schlesselman]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Case-Control Studies: Design, Conduct, Analysis]]></source>
<year>1982</year>
<publisher-name><![CDATA[Oxford University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="">
<collab>Ryan T</collab>
<source><![CDATA[Sample Size Determination and Power]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kleinbaum]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Klein]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Logistic Regression: A Self-Learning Text]]></source>
<year>2002</year>
<edition>2nd</edition>
<publisher-loc><![CDATA[Springer ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hosmer]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
<name>
<surname><![CDATA[Lemeshow]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Applied Logistic Regression]]></source>
<year>2000</year>
<edition>2nd</edition>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prga]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Radman]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Leppée]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Culig]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Maric-Bajs]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of SMS reminders to increase the hypertensive patients' adherence to medication: Marcel Leppée]]></article-title>
<source><![CDATA[Eur J Public Health]]></source>
<year>2016</year>
<volume>26</volume>
<numero>^sSuppl 1</numero>
<issue>^sSuppl 1</issue>
<supplement>Suppl 1</supplement>
<page-range>ckw174.111</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Teshome]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
<name>
<surname><![CDATA[Bekele]]></surname>
<given-names><![CDATA[KB]]></given-names>
</name>
<name>
<surname><![CDATA[Habitu]]></surname>
<given-names><![CDATA[YA]]></given-names>
</name>
<name>
<surname><![CDATA[Gelagay]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medication adherence and its associated factors among hypertensive patients attending the Debre Tabor General Hospital, northwest Ethiopia]]></article-title>
<source><![CDATA[Integr Blood Press Control]]></source>
<year>2017</year>
<volume>10</volume>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<collab>NCD Risk Factor Collaboration (NCD-Risk)</collab>
<article-title xml:lang=""><![CDATA[Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries an analysis of 123 nationally representative surveys]]></article-title>
<source><![CDATA[The Lancet]]></source>
<year>2019</year>
<volume>394</volume>
<numero>10199</numero>
<issue>10199</issue>
<page-range>639-51</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sandoval]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Nazzal]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Romero]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical, Socioeconomic, and Psychosocial Factors Associated with Blood Pressure Control and Adherence Results from a Multidisciplinary Cardiovascular National Program Providing Universal Coverage in a Developing Country]]></article-title>
<source><![CDATA[Int J Hypertens]]></source>
<year>2018</year>
<volume>2018</volume>
<page-range>5634352</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Burnier]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Egan]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherence in Hypertension]]></article-title>
<source><![CDATA[Circ Res]]></source>
<year>2019</year>
<volume>124</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1124-40</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Woodham]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Taneepanichskul]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Somrongthong]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Auamkul]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medication adherence and associated factors among elderly hypertension patients with uncontrolled blood pressure in rural area, Northeast Thailand]]></article-title>
<source><![CDATA[J Heal Res]]></source>
<year>2018</year>
<volume>32</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>449-58</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Palafox]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Goryakin]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Suhrcke]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Balabanova]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Yusuf]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[McKeeet]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Can social capital overcome barriers to effective management of hypertension Study in 17 countries: Martin McKee]]></article-title>
<source><![CDATA[Eur J Public Health]]></source>
<year>2016</year>
<volume>26</volume>
<numero>^sSuppl 1</numero>
<issue>^sSuppl 1</issue>
<supplement>Suppl 1</supplement>
<page-range>ckw164.068</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Niessen]]></surname>
<given-names><![CDATA[MAJ]]></given-names>
</name>
<name>
<surname><![CDATA[van der Hoeven]]></surname>
<given-names><![CDATA[NV]]></given-names>
</name>
<name>
<surname><![CDATA[van den Born]]></surname>
<given-names><![CDATA[B-JH]]></given-names>
</name>
<name>
<surname><![CDATA[van Kalken]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
<name>
<surname><![CDATA[Kraaijenhagen]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Home blood pressure measurement as a screening tool for hypertension in a web-based worksite health promotion programme]]></article-title>
<source><![CDATA[Eur J Public Health]]></source>
<year>2014</year>
<volume>24</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>776-81</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bergonzoli]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Epidemiologia y Estadística: 1001 Preguntas [Lo Que No Se Atrevio a Preguntar, Pero Siempre Quiso Saber]]]></source>
<year>2019</year>
<publisher-name><![CDATA[IMPRETICS E.I.C.E]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
